Syneos Health

Syneos Health is a global clinical research organization (CRO) and healthcare solutions company that provides integrated clinical development, commercialization, and technology-enabled research services to pharmaceutical, biotechnology, and healthcare organizations worldwide. Founded in 2018 through the merger of INC Research and inVentiv Health, Syneos Health is headquartered in Morrisville, North Carolina, United States.

The company specializes in clinical trial management, Phase I–IV clinical research, patient recruitment, clinical data management, regulatory support, pharmacovigilance, biostatistics, medical writing, and decentralized clinical trial solutions. Syneos Health supports sponsors throughout the entire clinical development process, from early-stage research to regulatory approval and post-market studies.

Syneos Health operates a global network of clinical research professionals, investigators, healthcare sites, and technology platforms across multiple therapeutic areas, including oncology, neuroscience, immunology, rare diseases, cardiovascular medicine, and vaccines.

The company uses innovative technologies, real-world data solutions, artificial intelligence, and patient-centric approaches to improve clinical trial efficiency and participation. Its integrated model combines clinical operations and healthcare commercialization expertise to help organizations accelerate the delivery of new therapies.

Syneos Health follows strict global research standards, including Good Clinical Practice (GCP), regulatory requirements from agencies such as the FDA and EMA, and international quality management systems.

With a presence in more than 110 countries and extensive experience managing complex global studies, Syneos Health plays an important role in advancing clinical research and helping healthcare innovators bring new treatments to patients faster.